Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study

Autor: Kenneth K C Man, Alexander Häge, Tobias Banaschewski, Sarah K Inglis, Jan Buitelaar, Sara Carucci, Marina Danckaerts, Ralf W Dittmann, Bruno Falissard, Peter Garas, Chris Hollis, Kerstin Konrad, Hanna Kovshoff, Elizabeth Liddle, Suzanne McCarthy, Antje Neubert, Peter Nagy, Eric Rosenthal, Edmund J S Sonuga-Barke, Alessandro Zuddas, Ian C K Wong, David Coghill, Tessa Couper, Gabriele Masi, Antonella Gagliano, Marco Lamberti, Dino Maschietto, Antonella Costantino, Paola Morosini, Maria Elisa Fazzi, Klaus-Ulrich Oehler, Martina Pitzer, Jörg Fegert, Frank Häßler, Tobias Renner, Fabian Härtling, Marcel Romanos, Adam Alfred, Veit Roessner, Susanne Wallitza, Henrik Uebel-von Sandersleben

Publikováno v: The Lancet Psychiatry. 10:323-333

BACKGROUND: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD in children and adolescents in many countries. Although many randomised controlled trials support short-term efficacy, tolerability, and safety, data o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::983a4f121200f2d11293e2e590d63d9b
https://doi.org/10.1016/s2215-0366(23)00042-1

Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)

Autor: Suzanne McCarthy, Antje Neubert, Kenneth K. C. Man, Tobias Banaschewski, Jan Buitelaar, Sara Carucci, David Coghill, Marina Danckaerts, Bruno Falissard, Peter Garas, Alexander Häge, Chris Hollis, Sarah Inglis, Hanna Kovshoff, Elizabeth Liddle, Konstantin Mechler, Peter Nagy, Eric Rosenthal, Robert Schlack, Edmund Sonuga-Barke, Alessandro Zuddas, Ian C. K. Wong

Publikováno v: BMC Psychiatry, Vol 18, Iss 1, Pp 1-10 (2018)

Abstract Background Concerns have been raised over the safety of methylphenidate (MPH), with regard to adverse effects on growth and blood pressure. Our study investigates whether, and to what extent, methylphenidate use in boys with ADHD is associat

Externí odkaz: https://doaj.org/article/f1dbef68d02e4a6abd99f21944f43373

Long-term suicide risk of children and adolescents with attention deficit and hyperactivity disorder – a systematic review

Autor: Peter Garas, Judit Balazs

Publikováno v: Frontiers in Psychiatry
Frontiers in Psychiatry, Vol 11 (2020)

Background: Attention deficit and hyperactivity disorder (ADHD) is one of the most common mental disorders in childhood. Recently, several studies showed the high suicide risk of patients with ADHD; however, most of these studies had a cross-sectiona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61bc890bdb2c1704e263d3cb0706b805
https://doi.org/10.1192/j.eurpsy.2022.826

Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis

Autor: Roberta Romaniello, Edmund J.S. Sonuga-Barke, Sara Carucci, Angelico Lampis, Ian C. K. Wong, T. Usala, Hanna Kovshoff, Peter Nagy, Kerstin Konrad, S Inglis, Chris Hollis, C. Balia, Antonella Gagliano, Jan K. Buitelaar, David Coghill, Pietro Panei, Alessandro Zuddas, Peter Garas, Ralf W. Dittmann, Elizabeth B. Liddle, Suzanne McCarthy, Marina Danckaerts, Tobias Banaschewski

Publikováno v: Carucci, S, Balia, C, Gagliano, A, Lampis, A, Buitelaar, J K, Danckaerts, M, Dittmann, R W, Garas, P, Hollis, C, Inglis, S, Konrad, K, Kovshoff, H, Liddle, E B, McCarthy, S, Nagy, P, Panei, P, Romaniello, R, Usala, T, Wong, I C K, Banaschewski, T, Sonuga-Barke, E, Coghill, D, Zuddas, A & the ADDUCE Consortium 2021, ' Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis ', Neuroscience and Biobehavioral Reviews, vol. 120, pp. 509-525 . https://doi.org/10.1016/j.neubiorev.2020.09.031
Neuroscience & biobehavioral reviews 120, 509-525 (2021). doi:10.1016/j.neubiorev.2020.09.031
Neuroscience and Biobehavioral Reviews, 120, 509-525
Neuroscience and Biobehavioral Reviews, 120, pp. 509-525

Contains fulltext : 231767.pdf (Publisher’s version ) (Closed access) BACKGROUND: Methylphenidate (MPH) is an efficacious treatment for ADHD but concerns have been raised about potential adverse effects of extended treatment on growth. OBJECTIVES:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ab57a6fbe87b0bb991448e0ca66851
https://pure.au.dk/portal/da/publications/long-term-methylphenidate-exposure-and-growth-in-children-and-adolescents-with-adhd-a-systematic-review-and-metaanalysis(1fbb9dd9-7c44-47f7-86de-7459f74809a7).html

Association of Risk of Suicide Attempts With Methylphenidate Treatment

Autor: Patrick Ip, Kerstin Konrad, Suzanne McCarthy, Peter Nagy, Edmund J.S. Sonuga-Barke, Sarah K. Inglis, Jan K. Buitelaar, Eric Rosenthal, Wallis C.Y. Lau, Esther W. Chan, David Coghill, Miriam C. J. M. Sturkenboom, Hanna Kovshoff, Alessandro Zuddas, Antje Neubert, Elizabeth B. Liddle, Ian C. K. Wong, Tobias Banaschewski, Chris Hollis, Alexander Häge, Martijn J. Schuemie, Sara Carucci, Kenneth K.C. Man, Kapil Sayal, Peter Garas

Publikováno v: JAMA Psychiatry, 74(10), 1048-1055. American Medical Association
JAMA Psychiatry, 74, 10, pp. 1048-1055
JAMA Psychiatry, 74, 1048-1055

IMPORTANCE: Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most common treatment for ADHD, but the association between their the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4465bf0194b7205117df4bdbc0cace00
https://hdl.handle.net/1765/102286